Literature DB >> 4028033

Deep venous thrombosis during therapy for Hodgkin's disease.

E J Seifter, R C Young, D L Longo.   

Abstract

Upon reviewing the case records of 177 patients with Hodgkin's disease, we identified ten patients (6%) with deep vein thromboses confirmed by diagnostic tests. Most of the patients initially presented with advanced Hodgkin's disease as defined by stage and constitutional symptoms. Thrombotic episodes usually occurred between cycles of chemotherapy in the absence of clinically detectable tumor. Infusion of chemotherapeutic vesicants may have contributed to the high proportion of upper extremity deep venous thrombosis in this series. Thrombotic episodes did not necessarily imply recurrent disease. Three patients developed thromboses after completion of therapy and remained free of Hodgkin's disease or other malignancies at 85+, 18+, and 17+ months of follow-up.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4028033

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  5 in total

1.  Thromboses and thromboemboli in patients with lymphoma during cytotoxic chemotherapy.

Authors:  B M Cantwell; J Carmichael; S E Ghani; A L Harris
Journal:  BMJ       Date:  1988-07-16

Review 2.  Venous thromboembolism in hematopoietic stem cell transplant recipients.

Authors:  S Chaturvedi; A Neff; A Nagler; U Savani; M Mohty; B N Savani
Journal:  Bone Marrow Transplant       Date:  2015-12-21       Impact factor: 5.483

3.  Is there any effect of lower extremity deep vein thrombosis which proven by Doppler ultrasonography on cancer recurrence in patients with stage III colon cancer? A study of the Turkish Descriptive Oncological Researches Group.

Authors:  Ozgur Tanriverdi; Birdal Yildirim; Suha Gul; Esin Cevik; Tulay Akman; Suna Cokmert; Kezban Nur Pilanci; Nilufer Avci; Cetin Ordu; Sabri Barutca
Journal:  Med Oncol       Date:  2014-09-11       Impact factor: 3.064

Review 4.  Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis.

Authors:  Freesia Horsted; Joe West; Matthew J Grainge
Journal:  PLoS Med       Date:  2012-07-31       Impact factor: 11.069

5.  Increased risk of thromboembolism in patients with malignant lymphoma: a single-centre analysis.

Authors:  M Mohren; I Markmann; K Jentsch-Ullrich; M Koenigsmann; G Lutze; A Franke
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.